Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KelSie Biotech is a biotechnology company based in Charlotte, North Carolina, specializing in advanced drug delivery systems. The company has developed a proprietary dry powder technology platform designed for sublingual, intranasal, and oral delivery of active pharmaceutical ingredients (APIs). Their technology is utilized to enhance the bioavailability and onset of action for various compounds, including nicotine, cannabinoids, and traditional pharmaceuticals like epinephrine. KelSie Biotech primarily operates through strategic partnerships and licensing agreements, providing its formulation expertise to companies in the consumer health and pharmaceutical sectors. The company's platform is notable for its ability to stabilize sensitive molecules and provide a rapid, non-invasive alternative to injections. Through its partnership with Kaival Brands, KelSie's technology has been integrated into commercial products such as the Bidi Stick.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KelSie Biotech.